Leafly (LFLY) Stock Price, News & Analysis (2024)

FAQs

Is Lfly a buy? ›

LFLY Analyst Recommendation Trends

In the current month, LFLY has received 2 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings.

Leafly Holdings, Inc. stock prediction for 1 year from now: $ 2.45 (2.61%) Leafly Holdings, Inc. stock forecast for 2025: $ 4.90 (104.88%) Leafly Holdings, Inc. stock prediction for 2030: $ 176.84 (7,295.11%)

Leafly went public via a special purpose acquisition corporation (SPAC) transaction in February 2022.

How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Leafly Holdings net worth as of May 06, 2024 is $0.01B. Leafly Holdings Inc. provides online cannabis discovery marketplace and resource for cannabis consumers.

Leafly has received a consensus rating of Moderate Buy.

The company's net income for 2022 was $5.1 million, compared with a net loss of $12 million in 2021. At the same time, Leafly reported: An adjusted EBITDA loss of $23.2 million compared with $9.4 million in 2021. A net loss in the fourth quarter of $5.8 million compared with $5.1 million in 2021.

Leafly's revenue primarily comes from a monthly subscription fee paid by cannabis retailers to be listed on the platform and to access e-commerce tools. More than 7,800 brands and 4,600 retailers use its services. Leafly also makes money from advertising.

Leafly is the world's most trusted destination to discover cannabis products and order them from legal, licensed retailers. More than 125 million people visit Leafly each year to learn more about cannabis and order online with local businesses.

Seattle cannabis marketplace company Leafly this week completed a 1-for-20 reverse stock split, consolidating its shares in an effort to remain compliant with Nasdaq listing requirements. Leafly went public last year in a SPAC deal, reaching a peak stock price of more than $11 in April 2022.

Who runs Leafly? ›

Leafly CEO Yoko Miyash*ta. A former Getty Images executive, Miyash*ta was previously the company's general counsel when she joined in 2019, and took over as CEO in August 2020. Leafly spun out of Seattle marijuana investment firm Privateer Holdings in 2019.

We are breaking down each platform to help you decide which one is the best fit for you and your business. Looking from the top down, Weedmaps is primarily focused on finding nearby dispensaries whereas Leafly has a more comprehensive database of products and strains alongside dispensary information.

Yoko Miyash*taCEO

Yoko Miyash*ta was appointed CEO of Leafly in August 2020 after serving as the company's General Counsel since 2019.

Leafly is headquartered in Seattle, WA, and was founded in 2010.

Welcome to Leafly

5,000+ strains. 1.3mm+ reviews. Legalization advocates with a social justice and equity mindset.

According to analysts, DMGI price target is 1.00 CAD with a max estimate of 1.00 CAD and a min estimate of 1.00 CAD.

Is FibroGen stock a Buy, Sell or Hold? FibroGen stock has received a consensus rating of sell.

What do analysts say about Genelux Corp.? Genelux Corp.'s analyst rating consensus is a Moderate Buy.

The Leju Holdings Limited stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock.